VALEANT PHARMACEUTICALS INTERNATIONAL Uncategorized Contracts & Agreements

45 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture Agreement for Valeant Pharmaceuticals International 6.75% Senior Notes Due 2017 and 7.00% Senior Notes Due 2020 with The Bank of New York Mellon Trust Company, N.A. as...
Indenture Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2010
Non-Executive Chairman and BLS President Agreement among Biovail Corporation, Biovail Laboratories International SRL, and William M. Wells
Severance Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2010
Employment Agreement between Biovail Corporation, Biovail Laboratories International SRL, and J. Michael Pearson (June 20, 2010)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NJ
2010
Pledge and Security Agreement between Valeant Pharmaceuticals International, Subsidiaries, and Goldman Sachs Bank USA (May 26, 2010)
Security Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2010
Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Subsidiaries, and Goldman Sachs Entities (May 26, 2010)
Credit Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2010
Membership Interest Purchase Agreement among Valeant Pharmaceuticals International, Princeton Pharma Holdings LLC, and Members (May 3, 2010)
Purchase Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2010
Employment Agreement between Valeant Pharmaceuticals International and J. Michael Pearson (2010)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NJ
2010
Standstill and Board Nomination Agreement between Valeant Pharmaceuticals International and ValueAct Capital Entities
Voting Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2009
Amendment to Executive Employment Agreement between Valeant Pharmaceuticals International and J. Michael Pearson (November 30, 2009)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2009
Product Commercialization Agreement between Mylan Pharmaceuticals Inc. and Dow Pharmaceutical Sciences, Inc.
Distribution Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2009
Employment Agreement between Valeant Pharmaceuticals International and Bhaskar Chaudhuri (March 10, 2009)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2009
Valeant Pharmaceuticals International Employment Offer Letter to Rajiv De Silva (Chief Operating Officer)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2009
Valeant Pharmaceuticals International Employment Offer Letter to Elisa Karlson (Chief Administrative Officer)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2009
Valeant Pharmaceuticals International Employment Agreement with Steve T. Min (Executive Vice President, General Counsel & Corporate Secretary)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2009
Separation and Release Agreement between Wesley P. Wheeler and Valeant Pharmaceuticals North America
Separation Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2008
Amendment to Asset Purchase Agreement between Valeant Pharmaceuticals North America and Three Rivers Pharmaceuticals, LLC (January 11, 2008)
Modification Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2008
Asset Purchase Agreement between Three Rivers Pharmaceuticals, LLC and Valeant Pharmaceuticals North America (December 19, 2007)
Purchase Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2008
Valeant Pharmaceuticals International 2006 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2007
Valeant Pharmaceuticals International Restricted Stock Unit Award Grant Notice (2006 Equity Incentive Plan)
Bonus & Incentive Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2007
Assignment and Assumption Agreement among Metabasis Therapeutics, Inc., Schering Corporation, and Valeant Research & Development (December 13, 2006)
Assignment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2007
Non-Executive Chairman Service Agreement between Valeant Pharmaceuticals International and Robert O’Leary
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2005
Amended and Restated Diastat Asset Purchase Agreement by and among Elan Pharmaceuticals, Inc., Elan Pharma International Limited, and Xcel Pharmaceuticals, Inc. dated March 31,...
Purchase Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2005
Asset Purchase Agreement for Retigabine between Viatris GmbH & Co. KG and Xcel Pharmaceuticals, Inc.
Purchase Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2005
Executive Employment Agreement between Ribapharm Inc. and Kim D. Lamon, MD, PhD
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2005
Executive Severance Agreement between Valeant Pharmaceuticals International and Eileen C. Pruette (April 22, 2005)
Severance Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2005
Valeant Pharmaceuticals International Underwriting Agreement with Bear, Stearns & Co. Inc. (February 3, 2005)
Underwriting Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2005
ICN Pharmaceuticals, Inc. Executive Employment Offer Letter to Eileen Pruette (March 3, 2003)
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2004
Amended and Restated Employment Agreement between ICN Pharmaceuticals, Inc. and Robert O'Leary
Employment Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2004
Valeant Pharmaceuticals International Common Stock Purchase Warrant Agreement (August 17, 2009)
Warrant Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2009
Amendment No. 1 to Agreement and Plan of Merger among Valeant Pharmaceuticals International and Harris Goodman as Stockholder Representative
Merger Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2009
First Amendment to License and Collaboration Agreement between Valeant Pharmaceuticals North America and Glaxo Group Limited
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2009
Amendment to Agreement and Plan of Merger among Coria Laboratories, DFB Pharmaceuticals, Valeant Pharmaceuticals, and Others
Merger Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2008
Agreement and Plan of Merger among Coria Laboratories, Ltd., Its Shareholders, Valeant Pharmaceuticals International, and CL Acquisition Corp.
Merger Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2008
Development and License Agreement between Valeant Research & Development and Schering Corporation (December 13, 2006)
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
NY
2007
Amendment No. Four to License and Commercialization Agreement between Amgen Inc. and InterMune, Inc.
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2006
Amendment No. Three to License and Commercialization Agreement between Amgen Inc. and InterMune, Inc.
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2006
Amendment No. 2 to Amgen/InterMune License and Commercialization Agreement for Infergen
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
2006
Amendment No. 1 to Amgen/InterMune License and Commercialization Agreement for Infergen
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2006
License and Commercialization Agreement between Amgen Inc. and InterMune, Inc. (June 15, 2001)
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
CA
2006
Development and License Agreement between Metabasis Therapeutics, Inc. and ICN Pharmaceuticals, Inc. dated October 1, 2001
License Agreements
VALEANT PHARMACEUTICALS INTERNATIONAL
Pharmaceuticals
DE
2005